
Sartel Beta Plus 12.5mg/50mg/40mg Tablet ER
Marketer
Intas Pharmaceuticals Ltd
Salt Composition
Chlorthalidone (12.5mg) + Metoprolol Succinate (50mg) + Telmisartan (40mg)
Overview Sartel Beta Plus 12.5mg/50mg/40mg Tablet ER
Hypertension treatment with the extended-release combination drug, Sartel Beta Plus (12.5mg/50mg/40mg), involves vasodilation and enhanced cardiac efficiency, promoting improved blood circulation. This medication also facilitates diuresis, eliminating excess fluid and electrolytes. Administer Sartel Beta Plus at the same time each day, regardless of food intake, to maximize therapeutic effect. Due to its diuretic action, daytime administration (or at least four hours before bedtime) is recommended to minimize nocturnal urination. Dosage and frequency are determined by your physician based on individual needs and should be followed precisely. Continuous use, as directed, is crucial for optimal management. Commonly reported side effects include nausea, diarrhea, gastrointestinal discomfort, headache, and dizziness. Regular monitoring of renal function and electrolyte levels is essential. Lifestyle modifications, including a balanced diet, regular physical activity, and smoking cessation, complement this medication for best results. Increased fluid intake can alleviate potential dryness of the mouth or thirst. Prior to initiating treatment, inform your physician of any pregnancy, circulatory disorders, liver or kidney impairment, or other medications you are currently using, as interactions may occur, impacting efficacy or medication response.
Uses of Sartel Beta Plus 12.5mg/50mg/40mg Tablet ER
Elevated arterial blood pressure
Major Benefits of Sartel Beta Plus 12.5mg/50mg/40mg Tablet ER:
Follow your doctor's instructions precisely regarding dosage and treatment length for Sartel Beta Plus 12.5mg/50mg/40mg Extended-Release Tablets. Ingest the tablet whole; avoid chewing, crushing, or breaking it. While this medication can be taken with or without food, consistent timing is recommended for optimal results.
Common Side effects of Sartel Beta Plus 12.5mg/50mg/40mg Tablet ER:
- Nausea
- Diarrhea
- Upset stomach
- Headache
- Dizziness
- Cold extremities
- Numbness of extremity
- Increased blood lipid level
- Slow heart rate
- Decreased blood pressure
How to use Sartel Beta Plus 12.5mg/50mg/40mg Tablet ER:
Follow your doctor's instructions precisely regarding the dosage and treatment length for Sartel Beta Plus 12.5mg/50mg/40mg Extended-Release Tablets. Ingest the tablet whole; avoid crushing, chewing, or breaking it. While this medication can be taken with or without food, consistent timing is recommended for optimal results.
How Sartel Beta Plus 12.5mg/50mg/40mg Tablet ER works:
Chlorthalidone, a diuretic, facilitates the urinary excretion of excess fluid and specific electrolytes. Its long-term effects include vasodilation and enhanced circulation. Metoprolol succinate, a beta-adrenergic blocking agent, reduces cardiac activity by slowing the heart rate. Conversely, Telmisartan, an angiotensin receptor blocker, lowers blood pressure via angiotensin II antagonism, resulting in further vasodilation.
SAFETY ADVICE
AlcoholUNSAFE
Combining Sartel Beta Plus 12.5mg/50mg/40mg Extended-Release Tablets with alcohol is inadvisable.
PregnancyCONSULT YOUR DOCTOR
Extended-release Sartel Beta Plus tablets (12.5mg/50mg/40mg) pose a confirmed risk to the unborn child and should not be taken during pregnancy. In exceptional, life-threatening circumstances, a physician might prescribe this medication if the potential benefits outweigh the known hazards. Always seek medical advice before use.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Sartel Beta Plus tablets (12.5mg/50mg/40mg) are likely unsafe for breastfeeding mothers. Available evidence indicates potential transfer to breast milk, posing a risk to the infant.
DrivingUNSAFE
Extended-release Sartel Beta Plus tablets (12.5mg/50mg/40mg) can induce drowsiness, blurred vision, and dizziness. Driving should be avoided if these effects are experienced.
KidneyCAUTION
Patients with severe kidney impairment should use Sartel Beta Plus 12.5mg/50mg/40mg Extended-Release tablets cautiously, potentially requiring dosage modification. Physician consultation is advised; in fact, use is generally discouraged in such cases.
LiverCAUTION
Patients with liver impairment should use Sartel Beta Plus 12.5mg/50mg/40mg Extended-Release tablets cautiously, potentially requiring dosage modification. Consult a physician for guidance. The use of Sartel Beta Plus 12.5mg/50mg/40mg Extended-Release tablets is contraindicated in individuals with severe hepatic dysfunction.
What if you forget to take Sartel Beta Plus 12.5mg/50mg/40mg Tablet ER :
Should you forget to take a Sartel Beta Plus 12.5mg/50mg/40mg Extended-Release tablet, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Sartel Beta Plus 12.5mg/50mg/40mg Tablet ER
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Heart |
